Drug intelligence / Profile preview

potassium chloride + sodium acetate + sodium gluconate + magnesium chloride + sodium chloride

Development stage
Approved
Lead developer
Takeda
Modality
Small Molecules
Administration
Intravenous
01

Overview

**Potassium chloride + sodium acetate + sodium gluconate + magnesium chloride + sodium chloride** is a sterile, nonpyrogenic, isotonic balanced crystalloid intravenous electrolyte solution marketed by Baxter as **Plasma-Lyte A**. It provides water plus sodium, potassium, magnesium, chloride, acetate, and gluconate to restore extracellular fluid volume and electrolyte balance. Acetate and gluconate are metabolized to bicarbonate precursors, producing an alkalinizing effect. Plasma-Lyte A is indicated as a source of water and electrolytes and as an alkalinizing agent; it has a pH of approximately 7.4 and calculated osmolarity of approximately 294 mOsmol/L. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6ec9e61c-2c26-402f-8604-f446b2e34058))

Brand names
Plasma-Lyte A
Other names
Multiple Electrolytes Injection Type 1Multiple Electrolytes Injection Type 1 USPPlasma-Lyte A Injection pH 7.4

Beyond the preview

Go deeper on potassium chloride + sodium acetate + sodium gluconate + magnesium chloride + sodium chloride.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on potassium chloride + sodium acetate + sodium gluconate + magnesium chloride + sodium chloride.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call